Review: taking Marinol and Gabapentin together


Summary

Drug interactions are reported among people who take Marinol and Gabapentin together. This review analyzes the effectiveness and drug interactions between Marinol and Gabapentin. It is created by eHealthMe based on reports of 245 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Marinol and Gabapentin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Marinol

Marinol has active ingredients of dronabinol. It is often used in nausea. (latest outcomes from Marinol 1,683 users)

Gabapentin

Gabapentin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Gabapentin 38,780 users)

On Jul, 24, 2016

245 people who take Marinol, Gabapentin are studied.


Number of reports submitted per year:

Marinol and Gabapentin drug interactions.

Drug effectiveness over time:

Marinol:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Gabapentin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Marinol:
  • female: 33.0% - (1 of 3 people)
  • male: 0.0% - (0 of 0 people)
Gabapentin:
  • female: 0.0% - (0 of 3 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Marinol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Gabapentin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • death
  • drug dependence
  • drug withdrawal syndrome
  • leukocytoclastic vasculitis
  • metastases to meninges
  • substance abuse
  • venous thrombosis limb
1 - 6 months:
  • fever
  • nausea and vomiting
  • stomach pain
  • sweating increased
  • vision blurred
  • vomiting
  • arthralgia
  • arthritis
  • catheter related complication
  • muscle spasticity
6 - 12 months:
  • tired eyes
  • vision blurred
  • vomiting
  • dizziness
  • fever
  • mood swings
  • nausea and vomiting
  • poor dental condition
  • stomach pain
  • sweating increased
1 - 2 years:
  • chest pain
  • dizziness
  • multiple sclerosis
2 - 5 years:
  • dizziness
not specified:
  • pain
  • nausea
  • pain in extremity
  • bone disorder
  • fatigue
  • vomiting
  • headache
  • back pain
  • osteonecrosis of jaw
  • dysuria

Most common drug interactions by gender *:

female:
  • pain
  • bone disorder
  • urinary tract infection
  • depression
  • headache
  • gastrooesophageal reflux disease
  • impaired healing
  • neuropathy peripheral
  • tooth extraction
  • diarrhoea
male:
  • pain
  • nausea
  • vomiting
  • arthralgia
  • asthenia
  • anxiety
  • infection
  • injury
  • fatigue
  • rash

Most common drug interactions by age *:

2-9:
  • malignant neoplasm progression
  • neuroblastoma
10-19:
  • cellulitis
  • chest pain
  • dehydration
  • haemoglobin decreased
  • neoplasm progression
  • neurilemmoma malignant
  • pain in extremity
  • platelet count decreased
  • pyrexia
  • vomiting
20-29:
  • fever
  • nausea and vomiting
  • stomach pain
  • sweating increased
  • vision blurred
  • vomiting
  • arthralgia
  • balance disorder
  • central nervous system lesion
  • diabetic ketoacidosis
30-39:
  • arthralgia
  • pain
  • asthenia
  • ecchymosis
  • generalised oedema
  • nephrogenic systemic fibrosis
  • oedema peripheral
  • petechiae
  • pigmentation disorder
  • purpura
40-49:
  • pain
  • constipation
  • back pain
  • osteonecrosis of jaw
  • dysuria
  • bone disorder
  • urinary tract infection
  • chest pain
  • abdominal pain
  • anxiety
50-59:
  • nausea
  • vomiting
  • fatigue
  • confusional state
  • mental status changes
  • pain
  • diarrhoea
  • pancytopenia
  • pleural effusion
  • asthenia
60+:
  • pain
  • depression
  • neuropathy peripheral
  • swelling
  • diarrhoea
  • bone disorder
  • gastrooesophageal reflux disease
  • impaired healing
  • muscular weakness
  • osteomyelitis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Marinol and Gabapentin?

Can you answer these questions?

More questions for: Marinol, Gabapentin

You may be interested in these reviews

More reviews for: Marinol, Gabapentin

On eHealthMe, Marinol (dronabinol) is often used to treat nausea. Gabapentin (gabapentin) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.